SCHEMBL25312201

SCHEMBL25312201

O=C(NC1CCN(C(=O)c2cccc(-c3cn4ccccc4n3)c2)CC1)c1ccnc(Nc2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
RAB9A P51151 4/20 0.52
LMNA P02545 2/20 0.52
POLB P06746 2/20 0.52
GFER P55789 1/20 0.52
NPC1 O15118 2/20 0.51
ALDH1A1 P00352 6/20 0.49
HPGD P15428 3/20 0.49
MAPT P10636 1/20 0.49
KMT2A Q03164 1/20 0.49
HPGDS O60760 3/20 0.46
ATR Q13535 3/20 0.45
SYK P43405 1/20 0.44
ROCK2 O75116 1/20 0.44
MAPK1 P28482 1/20 0.43
TP53 P04637 1/20 0.43
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29466302 1.00 KDM4E (0.52) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL29484624 0.89 RAB9A (0.56) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL25311588 0.89 RAB9A (0.56) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL25878981 0.89 KDM4E (0.54) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL29466348 0.88 KDM4E (0.51) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL25313050 0.88 KDM4E (0.51) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL25311960 0.84 KDM4E (0.56) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL25881212 0.82 KDM4E (0.49) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL25878621 0.81 RAB9A (0.57) KDM4ESMN1; SMN2RAB9ALMNAPOLB
SCHEMBL29466339 0.81 KDM4E (0.51) KDM4ESMN1; SMN2RAB9ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240101552-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2024-03-28 US disclosed
EP-4215526-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF Shanghai Pharmaceuticals Holding Co., Ltd. (CN) 2023-07-26 EP disclosed
CN-114195780-A Carbonyl heterocyclic compound and application thereof 上海医药集团股份有限公司 2022-03-18 CN disclosed
CN-114195806-A Carbonyl heterocyclic compound and application thereof 上海医药集团股份有限公司 2022-03-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101552-A1 CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOF LANCL2, CBS, LCP2 KDM4E 2757/4885SMN1; SMN2 3536/4885RAB9A 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.